Current recommendations for clinical surveillance and genetic testing in rhabdoid tumor predisposition: a report from the SIOPE host genome working group
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Familial Cancer, 20, S. 305-316
- Ereignis
-
Veröffentlichung
- (wo)
-
Augsburg
- (wer)
-
Universität Augsburg
- (wann)
-
2021
- Ereignis
-
Veröffentlichung
- (wer)
-
Springer Science and Business Media LLC
- (wann)
-
2021
- Urheber
-
Frühwald, Michael
Nemes, K.
Boztug, H.
Cornips, M. C. A.
Evans, D. G.
Farah, R.
Glentis, S.
Jorgensen, M.
Katsibardi, K.
Hirsch, S.
Jahnukainen, K.
Kventsel, I.
Kerl, K.
Kratz, C. P.
Pajtler, Kristian Wilfried
Kordes, U.
Ridola, V.
Stutz, E.
Bourdeaut, F.
- DOI
-
10.1007/s10689-021-00229-1
- URN
-
urn:nbn:de:bvb:384-opus4-835008
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Frühwald, Michael
- Nemes, K.
- Boztug, H.
- Cornips, M. C. A.
- Evans, D. G.
- Farah, R.
- Glentis, S.
- Jorgensen, M.
- Katsibardi, K.
- Hirsch, S.
- Jahnukainen, K.
- Kventsel, I.
- Kerl, K.
- Kratz, C. P.
- Pajtler, Kristian Wilfried
- Kordes, U.
- Ridola, V.
- Stutz, E.
- Bourdeaut, F.
- Universität Augsburg
- Springer Science and Business Media LLC
Entstanden
- 2021
Ähnliche Objekte (12)
Current recommendations for clinical surveillance and genetic testing in rhabdoid tumor predisposition: a report from the SIOPE Host Genome Working Group
BRD9 inhibition, alone or in combination with cytostatic compounds as a therapeutic approach in rhabdoid tumors
Bridging molecular advancements and clinical challenges in pediatric oncology
Non-malignant features of cancer predisposition syndromes manifesting in childhood and adolescence: a guide for the general pediatrician
Current and emerging therapeutic approaches for extracranial malignant rhabdoid tumors
EP-1382: Feasibility of proton therapy with concomitant chemotherapy for atypical teratoid rhabdoid tumors
The need for tumor surveillance of children and adolescents with cancer predisposition syndromes: a retrospective cohort study in a tertiary-care children’s hospital
Limbic encephalitis with LGI1 antibodies in a 14-year-old boy
Molecular subgrouping of atypical teratoid/rhabdoid tumors: a reinvestigation and current consensus
A retrospective 5-year single center study highlighting the risk of cancer predisposition in adolescents and young adults
Transposable element insertion as a mechanism of SMARCB1 inactivation in atypical teratoid/rhabdoid tumor
SWI/SNF-Komplex-assoziierte Tumordispositions-Syndrome
Current recommendations for clinical surveillance and genetic testing in rhabdoid tumor predisposition: a report from the SIOPE Host Genome Working Group
BRD9 inhibition, alone or in combination with cytostatic compounds as a therapeutic approach in rhabdoid tumors
Bridging molecular advancements and clinical challenges in pediatric oncology
Non-malignant features of cancer predisposition syndromes manifesting in childhood and adolescence: a guide for the general pediatrician
Current and emerging therapeutic approaches for extracranial malignant rhabdoid tumors
EP-1382: Feasibility of proton therapy with concomitant chemotherapy for atypical teratoid rhabdoid tumors
The need for tumor surveillance of children and adolescents with cancer predisposition syndromes: a retrospective cohort study in a tertiary-care children’s hospital
Limbic encephalitis with LGI1 antibodies in a 14-year-old boy
Molecular subgrouping of atypical teratoid/rhabdoid tumors: a reinvestigation and current consensus
A retrospective 5-year single center study highlighting the risk of cancer predisposition in adolescents and young adults
Transposable element insertion as a mechanism of SMARCB1 inactivation in atypical teratoid/rhabdoid tumor
SWI/SNF-Komplex-assoziierte Tumordispositions-Syndrome
Current recommendations for clinical surveillance and genetic testing in rhabdoid tumor predisposition: a report from the SIOPE Host Genome Working Group
BRD9 inhibition, alone or in combination with cytostatic compounds as a therapeutic approach in rhabdoid tumors
Bridging molecular advancements and clinical challenges in pediatric oncology
Non-malignant features of cancer predisposition syndromes manifesting in childhood and adolescence: a guide for the general pediatrician
Current and emerging therapeutic approaches for extracranial malignant rhabdoid tumors
EP-1382: Feasibility of proton therapy with concomitant chemotherapy for atypical teratoid rhabdoid tumors
The need for tumor surveillance of children and adolescents with cancer predisposition syndromes: a retrospective cohort study in a tertiary-care children’s hospital
Limbic encephalitis with LGI1 antibodies in a 14-year-old boy
Molecular subgrouping of atypical teratoid/rhabdoid tumors: a reinvestigation and current consensus
A retrospective 5-year single center study highlighting the risk of cancer predisposition in adolescents and young adults
Transposable element insertion as a mechanism of SMARCB1 inactivation in atypical teratoid/rhabdoid tumor